We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 9,120 results
  1. The (pro)renin receptor (ATP6ap2) facilitates receptor-mediated endocytosis and lysosomal function in the renal proximal tubule

    The ATP6ap2 (Pro)renin receptor protein associates with H + -ATPases which regulate organellar, cellular, and systemic acid–base homeostasis. In the...

    Marta Figueiredo, Arezoo Daryadel, ... Carsten A. Wagner in Pflügers Archiv - European Journal of Physiology
    Article Open access 06 July 2021
  2. Iron and Multiple Sclerosis

    Multiple sclerosis (MS) is a chronic autoimmune neurodegenerative disease followed by demyelination and axonal loss. There had been several reports...
    Anika, Rimpi Arora in Brain-Iron Cross Talk
    Chapter 2023
  3. Directing the Way—Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery

    Nucleic acid therapeutics have shown great potential for the treatment of numerous diseases, such as genetic disorders, cancer and infections....

    Ricarda Carolin Steffens, Ernst Wagner in Pharmaceutical Research
    Article Open access 15 September 2022
  4. Receptor-Specific Radionuclide Therapy

    Nuclear medicine is a medical specialty that uses radiopharmaceuticals for diagnostic imaging or therapy. This radiopharmaceutical compound consists...
    Nicolas Lepareur, Mickaël Bourgeois in Handbook of Cancer and Immunology
    Living reference work entry 2022
  5. Glutathione transporter as a target for brain drug delivery

    Inability to achieve therapeutic concentrations of a medication in the brain due to the blood brain barrier (BBB) is the major cause of treatment...

    **angming Guan in Medicinal Chemistry Research
    Article Open access 10 June 2024
  6. Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer

    Breast cancer (BC) is the most frequently diagnosed malignancy in women worldwide. Almost 70–80% of cases of BC are curable at the early...

    Mayur Aalhate, Srushti Mahajan, ... Pankaj Kumar Singh in Drug Delivery and Translational Research
    Article 16 February 2023
  7. Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis

    Blood brain barrier (BBB) models in vitro are an important tool to aid in the pre-clinical evaluation and selection of BBB-crossing therapeutics....

    Anna Jezierski, Jez Huang, ... Danica B. Stanimirovic in Fluids and Barriers of the CNS
    Article Open access 26 May 2023
  8. Central role of Sigma-1 receptor in ochratoxin A-induced ferroptosis

    Ochratoxin A (OTA), a secondary fungal metabolite known for its nephrotoxic effects, is prevalent in various feeds and food items. Our recent study...

    Wenying Chen, Lingyun Han, ... **ao Li Shen in Archives of Toxicology
    Article 19 June 2024
  9. Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer

    Purpose

    Radiation therapy (RT) and hormone receptor (HR) inhibition are used for the treatment of HR-positive breast cancers; however, little is known...

    Anna R. Michmerhuizen, Lynn M. Lerner, ... Corey W. Speers in British Journal of Cancer
    Article Open access 26 May 2022
  10. Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood–Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial Cells

    Purpose

    The insulin receptor (INSR) mediates insulin signaling to modulate cellular functions. Although INSR is expressed at the blood–brain barrier...

    Hinako Nagano, Shingo Ito, ... Sumio Ohtsuki in Pharmaceutical Research
    Article 22 November 2021
  11. Plasmodium vivax merozoite-specific thrombospondin-related anonymous protein (PvMTRAP) interacts with human CD36, suggesting a novel ligand–receptor interaction for reticulocyte invasion

    Background

    The Plasmodium vivax merozoite restrictively invades immature erythrocytes, suggesting that its ligand(s) might interact with...

    Thau Sy Nguyen, Ji-Hoon Park, ... Eun-Taek Han in Parasites & Vectors
    Article Open access 19 November 2023
  12. Transferrin Receptor and Targeting Strategies

    Treatment of cancer is an extraordinary challenge using conventional therapy due to serious side effects. Targeted delivery of therapeutics has...
    Harsh A. Joshi, Esha S. Attar, ... Padma V. Devarajan in Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
    Chapter 2019
  13. LRP1 is a neuronal receptor for α-synuclein uptake and spread

    Background

    The aggregation and spread of α-synuclein (α-Syn) protein and related neuronal toxicity are the key pathological features of Parkinson’s...

    Kai Chen, Yuka A. Martens, ... Na Zhao in Molecular Neurodegeneration
    Article Open access 02 September 2022
  14. Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects

    Alcohol-associated liver disease (ALD) is one of the most common chronic liver diseases. Its pathological spectrum includes the overlap** stages of...

    Kevin Ferrao, Najma Ali, Kosha J. Mehta in Journal of Molecular Medicine
    Article Open access 10 October 2022
  15. Estrogen Up-Regulates Iron Transporters and Iron Storage Protein Through Hypoxia Inducible Factor 1 Alpha Activation Mediated by Estrogen Receptor β and G Protein Estrogen Receptor in BV2 Microglia Cells

    Estrogen is a steroid hormone produced mainly by the ovaries. It has been found that estrogen could regulate iron metabolism in neurons and...

    Yan Qu, Na Li, ... Jun Wang in Neurochemical Research
    Article 12 July 2022
  16. Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4

    Background

    The lactate receptor GPR81 contributes to cancer development through unclear mechanisms. Here, we investigate the roles of GPR81 in...

    Kathrine Lundø, Oksana Dmytriyeva, ... Stine F. Pedersen in BMC Cancer
    Article Open access 22 November 2023
  17. Species dependence of A3 adenosine receptor pharmacology and function

    Efforts to fully understand pharmacological differences between G protein-coupled receptor (GPCR) species homologues are generally not pursued in...

    Zhan-Guo Gao, John A. Auchampach, Kenneth A. Jacobson in Purinergic Signalling
    Article 20 December 2022
  18. The Study of Biological Activity of a New Thieno[2,3-D]-Pyrimidine-Based Neutral Antagonist of Thyrotropin Receptor

    The development of low-molecular-weight antagonists of thyroid-stimulating hormone (TSH) receptor is a promising trend in the treatment of autoimmune...

    K. V. Derkach, E. A. Fokina, ... A. O. Shpakov in Bulletin of Experimental Biology and Medicine
    Article 01 April 2022
  19. Dyshomeostasis of Iron and Its Transporter Proteins in Cypermethrin-Induced Parkinson’s Disease

    The etiology of Parkinson’s disease (PD) is highly complex and is still indefinable. However, a number of studies have indicated the involvement of...

    Nidhi Sachan, Neha Tiwari, ... Mahendra Pratap Singh in Molecular Neurobiology
    Article 23 June 2023
  20. Nuclear translocation of STAT5 initiates iron overload in huntington’s disease by up-regulating IRP1 expression

    Mutant huntingtin (mHtt) proteins interact to form aggregates, disrupting cellular functions including transcriptional dysregulation and iron...

    Li Niu, Yongze Zhou, ... Wei Zeng in Metabolic Brain Disease
    Article 23 January 2024
Did you find what you were looking for? Share feedback.